With significant expertise in the life sciences sector, Horn & Co‘s team advises clients on complex IP transactions, ranging from development agreements to the acquisition and licensing of intellectual property. Practice head Yuval Horn is noted for representing high-tech and life sciences companies in all their IP-related operations, while corporate finance and commercial transactions expert Keren Kanir is regularly engaged by venture capital funds and private and public companies in cross-border transactions with key IP aspects.
Testimonials
Collated independently by Legal 500 research team.
‘Very professional, dedicated and effective.’
Key clients
- Scopio Labs Ltd.
- Diagnostic Robotics Ltd.
Work highlights
- Represented INX Digital Company, which entered into a series of agreements with Republic, a billion-dollar US company, for a multistep financial and commercial development collaboration.
- Represented the shareholders of Immunorizon, a private pharma company, in an acquisition through a share purchase agreement with Purple Biotech.